ArticleJournal of Ayurveda and integrative medicine
Potential anticancer activity of Shulva Yoga, a herbo-metallic compound, in loss of scrib induced cancer in Drosophila melanogaster.
Article in Journal of Ayurveda and integrative medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe worldwide burden of cancer is illustrated by the 10.0 million fatalities (World Health Organization, 2021) and the 19.3 million incidence of new cases as reported in the GLOBOCAN data. The transparency to sensitiveness of chromosomal aberrations and the consequent responses in epithelial cancer quotients collectively explains the need of tumor exploration in Drosophila models.
objectiveThe reciprocation of a traditional herb-mineral combination Shulva Yoga (SY) in epithelial tumour microenvironment has been fundamentally assessed here. MATERIAL AND
methodsClassically incinerated copper ash were mixed for levigation with madyantika (Lawsonia inermisL.), punarnava (Boerhaavia diffusaL.) and meshshringi[Gymnema sylvestre (Retz.) Schult.] leaves. The in-vitro analysis of MTT and AnnexinV/PI staining were applied on four different cell lines (DL, JE6.1, MCF-7,& WRL-68) with SY. The in-vivo analysis was initiated with loss of scribble (cell polarity protein) in wing imaginal disc of Drosophila melanogaster for epithelial carcinoma induction. The dose determination was followed with pupal lethality assessment and anti-oxidant levels. The Phalloidin/F-actin filament, DAPI and Immunostaining were further implied.
resultsThe IC50 of SY treated DL, JE6.1, MCF-7 and WRL-68 cells at 24 hours was 28.25±1.5 μg, 27.27±1.6 μg, 37.59±1.9 μg, 15.92±2.5 μg respectively. The dosedependent range of 0.01 mg/ml to 0.2 mg/ml exhibited the features of early and late apoptosis after 24hrs with AnnexinV/PI stain. SY showed early pupal rescue, preservation of Actin filaments, downregulation of MMP 1and cyclin-E in comparison to the untreated. There was surge of the SOD and catalase levels, whereas LPO content depressed.
conclusionSY might induce apoptosis in tumour cells with counter mechanisms on angiogenesis, proliferation and metastasis in Drosophila model. Gene amplification, protein specificity, etc are the future prospects of present work.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.